Novo Nordisk targets bigger slice of diabetes market with new tablet

Danish drugmaker Novo Nordisk is aiming for a big slice of the multibillion-dollar diabetes market with a new pill, approved by U.S. authorities on Friday, that caters for patients with an aversion to needles.

from Reuters: Health News https://ift.tt/2kP8rTv
via IFTTT